Potential target for treatment of aggressive brain cancer identified
Wednesday, June 7, 2017 - 13:02
in Health & Medicine
Researchers have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme (GBM), the most malignant cancer of the brain.